Design and analysis issues in studies of gene-environment.
Authors
Paolo V; Schulte P; Carreon T; Bailer AJ; Medvedovic M
Source
EPICOH 16th International Conference on Epidemiology in Occupational Health, Barcelona, Spain, September 14, 2002. Rome, Italy: International Commission on Occupational Health, 2002 Sep; :1-9
Link
NIOSHTIC No.
20027176
Abstract
Making sense from population studies incorporating genes and environment has a rich history, but one fraught with problems. The nature-nurture debate has given way to the fundamental realization that both genes and environment play a role in disease, especially cancer. Interaction has been defined in several ways, for example as "the coparticipation of two or more agents in the same casual mechanism leading to disease development" (Yang and Khoury, 1997). According to a more generally accepted definition, interaction occurs when the effect of multiple factors differs from the effect predicted on the basis of the separate effects of each of the factors. Interactions need to be explicitly considered in the design and analysis of epidemiologic studies. If only the association between a genotype and disease is examined, the effect of biologic interaction cannot be appreciated (Khoury et al., 1993). Epidemiologists need to measure relevant risk factors, in addition to genotype(s). Also, it is likely that each exposure interacts with genes along a pathway (typically: DNA repair genes), so that multiple interactions are likely to be the norm. Evidence for a three-way interaction as showed by Taylor et a1., (1998) for NAT2 and NAT1 genotypes and smoking as risk factors for bladder cancer. Depending on the type of model for gene-environment interaction, risk estimates can vary dramatically. At least five different types of gene-environment interaction have been described (Khoury and Wagener, 1995). These have been generally considered with the dichotomous conditions, a single susceptibility genotype (present or absent), and a single enviromenta1 factor (present or absent). For example, in one analysis (Ottman, 1996) the risk to an exposed person with a rare (I % prevalence) susceptibility genotype ranges from 8% (under a multiplicative model of interaction) to 95.6% (when we assume that the exposure has no effect in susceptibles, but the genotype raises risk in unexposed as well as exposed persons).
Keywords
Case-studies; Mortality-rates; Mortality-data; Mortality-surveys; Morbidity-rates; Epidemiology; Statistical-analysis; Cancer-rates; Cancer
Publication Date
20020914
Document Type
Abstract
Fiscal Year
2002
NIOSH Division
EID
Source Name
EPICOH 16th International Conference on Epidemiology in Occupational Health, Barcelona, Spain, September 14, 2002
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.